Numerous laboratory tests have been devised and used with varying enthusiasm as aids in the diagnosis of rheumatic fever, but the establishment of the intimate relationship between this condition and upper respiratory tract streptococcal infection has directed interest mainly to the demonstration of serological evidence of streptococcal activity in rheumatic subjects. Of the various tests used for this purpose, the antistreptolysin "O", originally introduced by Todd (1932a, b) , has emerged as the most reliable and consistent, but as yet there is no general agreement as to its true value, possibly due to lack of understanding of its interpretation and limitations.
In this laboratory the estimation of antistreptolysin "O" titres (A.S.L.T.) was undertaken, in the first place, as part of a study on rheumatic heart disease in conjunction with the late area cardiologist, Dr. J. W. Brown. However, it rapidly became established in the area as a routine test in the investigation of acute rheumatism and other diverse clinical conditions. The experience gained from the interpretations of over 4,000 titrations performed during the past 9 years is summarized below.
Material
The subjects were drawn from general hospitals, from the Hull Rheumatic Unit, and from private practice. There were 363 cases of acute rheumatism, 114 of acute nephritis, and 315 others, making a total of 792 (Table I ).
Methods
The method described by Hodge and Swift (1933) In both diseases titres of 800 to 1,200 units were commonly found, and two cases of acute nephritis and one of acute rheumatism showed the very high titre of 10,000 units/ml. No statistically significant difference was found between the results in children and in adults, but few children were examined.
Other Illnesses (Table III and Fig. 1 ).-In 39 cases of known streptococcal infection (mainly puerperal pyrexia and scarlet fever) where haemolytic streptococci (group A with very few group C or G) had been isolated, a similar pattern of distribution of reactivity was found.
In 53 cases of "flitting joint pains" and in 25 cases of acute pericarditis about 50 per cent. were reactors.
177 cases of mitral stenosis and 21 cases of subacute bacterial endocarditis showed a similar pattern, with a low percentage of positives consisting mainly of low reactors. 
Antistreptolysin Response in Rheumatic Fever
The A.S.L.T. in patients with rheumatic fever usually shows a special pattern with an initial lag and a slow rise to a maximum in 5 to 6 weeks (after the initial sore throat), slowly tapering off over a period of several weeks. Cases with complications (e.g. carditis or relapse) show a striking see-saw pattern (Coburn, 1936; Rothbard, Watson, Swift, and Wilson, 1948) .
The drop of the antistreptolysin titre almost always lags behind that of the erythrocyte sedimentation rate and in many cases the A.S.L.T. continues to rise while the E.S.R. is falling.
Case Notes Fig. 2 (opposite) shows a typical sequence of events in an uncomplicated "monocyclic" case of rheumatic fever, in a girl aged 7 years with a history of joint pains and pyrexia of 4 to 5 days' duration when first seen by her doctor. She had complained of sore throat 3 weeks before the onset of joint pains. Her response to salicylate therapy was excellent and she made an uneventful recovery. Fig. 3 (opposite) shows a typical course in a case of rheumatic fever of the relapsing or "polycyclic" type, in a girl aged 11 years, who had her first relapse during her initial stay in hospital. She was kept under observation as an out-patient for a considerable time, mainly because of (I) (2) (3) (4) (5) (6) (7) group.bmj.com on October 14, 2017 -Published by http://ard.bmj.com/ Downloaded from the persistent elevation of the antistreptolysin titre, and was eventually re-admitted 15 months later with sore throat, joint pains, and active carditis. On this occasion a haemolytic streptococcus was isolated from the throat, and she was treated with penicillin.
Discussion
To interpret the results of the test, it is essential to know the normal antistreptolysin level. Whilst most workers agree that 200 Todd units/ml. or above is abnormal (Rantz, Randall, and Rantz, 1948; Rantz, 1955) , many have considered this figure or even 250 units as the upper limit of normality (Wood and McCarty, 1954; Hollinger, 1953 (Table II) ; even in cases of active streptococcal infection 20 per cent. of the subjects failed to develop this antibody. This, however, need not detract from the value of the test if the following points are borne in mind:
(1) The A.S.L.T. is not a test for rheumatic fever or acute nephritis, but a test for evidence of activity of Lancefield's Group A streptococci (or occasionally Groups C and G). As such, the intensity of the response necessarily varies with the duration of activity of the stimulus. Therefore the duration of the antecedent sore throat, the type of treatment then administered, and a history of previous attacks are important factors. While serological evidence may be detected during the second week after the infection, the maximum response does not generally develop before 5 or 6 weeks and may be partially suppressed by antibiotic therapy (Kilbourne and Loge, 1948) . On the other hand, during a relapse, the titre rises much more quickly and to higher levels. (2) Different strains of Group A streptococci vary greatly in their antigenic capacity (Lancefield and Stuart, 1944; Herbert and Todd, 1944) .
(3) The antibody response mechanism in certain individuals is sluggish (Wilson and Miles, 1955) .
It should also be recalled that Group A streptococci produce an extraordinary variety of extracellular substances, several of which (including streptolysin, hyaluronidase, and streptokinase) stimulate the production of readily measurable antibodies. Some investigators, by testing for a sufficient number of these antibodies, have been able to demonstrate that approximately 100 per cent. of their rheumatic fever cases show unequivocal response to at least one of these streptococcal components (Rothbard and others, 1948) .
These other tests, however, are difficult to perform and to standardize, and remain as yet in the domain of pure research, while the antistreptolysin has proved accurate and reliable and appears to be the one likely to yield most information if its limitations are well understood.
It is therefore important to emphasize the following points: (I) No matter what the initial A.S.L.T. may be, the demonstration of a rise in titre should be sought in all cases with initial low levels. At least two to three repeated titrations at not less than 1-week intervals may be necessary to establish the presence or absence of a significant response. A four-fold or two-tube rise in a straight doubling dilution is accepted as significant. (2) Although the absence of a rise in titre does not necessarily exclude recent streptococcal infection, a persistent titre of 50 or less is almost certain evidence against rheumatic fever or acute glomerulo-nephritis, and such a result at least merits a critical re-assessment of the clinical diagnosis (Wood and McCarty, 1954 (Brown, 1958) . There is also some evidence that patients with high-titre antibodies are more prone to develop the post-valvotomy syndrome (Din, 1958) (2) The limitations of the test arise from the difficulty of defining normal and abnormal antistreptolysin levels and from the failure of some patients to react. These points are discussed.
(3) The importance is stressed of repeating titrations in order to establish a significant serological response.
(4) The usefulness of the test in conditions other than acute rheumatism is discussed. (2) Les limitations de la reaction viennent de la difficulty de definir les taux normaux et pathologiques de l'antistreptolysine et du fait que certains malades n'y reagissent pas. On discute ces points.
(3) On souligne l'importance des dosages rep~tes pour obtenir des reponses serologiques significatives.
(4) On discute l'utilite de la reaction dans des maladies distinctes du rhumatisme aigu.
Uso e interpretaci6n del test de la antiestreptolisina SUMARIO (1) Se da un andlisis de los resultados de mas de 4,000 determinaciones de antistreptolisina (792 casos). Titulos significativos (200 unidades por c.c. o mAs) fueron obtenidos en el 80 al 85 por ciento de los casos de reumatismo agudo, nefritis aguda y en casos comprobados de infecci6n por estreptococo hemolitico.
(2) Las limitaciones del test nacen de la dificultad de definir los niveles normal y patol6gico de antistreptolisina y del fallo de ciertos enfermos en reaccionar. Son discutidos estos puntos. (3) Se insiste sobre la importancia de repetir las titulaciones en orden a establecer una respuesta serol6gica significative.
(4) Se discute la utilidad de la prueba en enfermedades distintas al reumatismo agudo.
